Abstract
COVID-19 has killed more than 7600 people in Chicago, Illinois, as of April 2022.1 Structural racism, defined as differential access to goods, services, and opportunities by race, has played a substantial role in COVID-19 disparities across the country. In Chicago, Black and Hispanic residents have been disproportionately affected. By the end of the first wave in 2020, Black residents made up 43% of COVID-19 deaths despite being 29% of Chicago’s population, and Hispanic residents made up 48% of COVID-19 cases despite also being 29% of Chicago’s population.2 Previous studies have also found spatial correlation between the percentage of residents identifying as Black and number of COVID-19 deaths within a Chicago neighborhood.3,4 After the US Food and Drug Administration (FDA) granted Emergency Use Authorization for COVID-19 vaccines, a common goal of phased implementation plans across the country was to mitigate racial inequities in COVID-19 outcomes. However, predominantly White and high-income communities were often the first to receive vaccines in major cities.5 To our knowledge, few studies have quantified the associations of inequitable vaccine coverage with severe COVID-19 outcomes in a major US city.

This publication has 19 references indexed in Scilit: